ISRCTN12655391
Completed
未知
A feasibility study and randomised controlled trial of acceptance and COMmitment therapy for people with Motor nEuroN Disease (COMMEND)
niversity College London Hospitals NHS Foundation Trust0 sites206 target enrollmentJuly 17, 2017
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Motor neuron disease
- Sponsor
- niversity College London Hospitals NHS Foundation Trust
- Enrollment
- 206
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/36380299/ (added 23/11/2022) 2023 Results article in https://doi.org/10.1186/s40814-023-01354-7 Co-primary feasibility and acceptability outcomes (added 10/07/2023) 2024 Results article in https://pubmed.ncbi.nlm.nih.gov/38735299/ Effectiveness of ACT (added 17/05/2024)
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Aged 18 years and over
- •2\. Diagnosis of familial or sporadic MND (or amyotrophic lateral sclerosis, which is diagnostically synonymous with MND) \- diagnosed as definite, laboratory\-supported probable or probable according to the World Federation of Neurology’s El Escorial criteria
Exclusion Criteria
- •1\. Need for gastrostomy feeding or non\-invasive ventilation (i.e. those in stages 4A or 4B of the King’s College London clinical staging system)
- •2\. Comorbid diagnosis of any form of dementia using standard diagnostic guidelines
- •3\. Already receiving ongoing formal psychological therapy (e.g. Cognitive Behavioural Therapy, psychodynamic psychotherapy, systemic therapy, counselling, etc) at the baseline assessment or unwilling to refrain from engaging in such formal psychological therapy during the receipt of ACT
- •4\. Insufficient understanding of English to enable engagement in the intervention and completion of patient\-reported outcome measures
- •5\. Lacking capacity to provide fully informed written consent, verbal consent (for those who cannot provide written consent), or consent via the use of a communication aid
- •6\. Requiring treatment for a severe psychiatric disorder such as schizophrenia, bipolar disorder, or suicidal ideation with active plans/suicidal behaviours and intent
- •7\. For Phase 2 only: Already participated in Phase 1
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Can we do a study to prevent cognitive decline with hearing aids?Cognitive declineMental and Behavioural DisordersISRCTN84550071niversity Medical Center Utrecht24
Completed
Not Applicable
Feasibility study of an randomised controlled trial to investigate the whether a robot (KASPAR) can improve the social skills of children with an Autism Spectrum DisorderSpecialty: Children, Primary sub-specialty: General PaediatricsUKCRC code/ Disease: Mental Health/ Behavioural and emotional disorders with onset usually occurring in childhood and adolescenceMental and Behavioural DisordersAutism Spectrum Disorder (ASD)ISRCTN14156001Hertfordshire Community NHS Trust40
Active, not recruiting
Not Applicable
A study to evaluate operation of flexor tendon injury under local anaesthesia compared to general or regional anaesthesiaISRCTN15052559Royal Free London NHS Foundation Trust60
Completed
Phase 4
PREVENTING PNEUMOcoccal disease through vaccination: PREVENTING PNEUMO 2PneumoniaRespiratoryISRCTN15728847iverpool School of Tropical Medicine516
Completed
Not Applicable
Joint PREP: Joint PRehabilitation with Exercise and ProteiTotal hip or knee replacement surgeryMusculoskeletal DiseasesISRCTN11121506orth Bristol NHS Trust64